TARIS Biomedical

Developing powerful and targeted new treatments for the millions of patients suffering from difficult-to-treat bladder diseases.

Launch date

2008

Employees

Market cap

Enterprise valuation

Lexington Kentucky (HQ)

Date	Investors	Amount	Round
-	Roman Abramovich Bristol-Myers Squibb Yonghua Capital Third Rock Ventures Flybridge Capital Partners	N/A	-
Jun 2009	N/A	$15.0m	Series A
Dec 2009	N/A	$5.0m	Series A
Jul 2010	N/A	$1.2m	Early VC
Nov 2010	N/A	$1.2m	Early VC
Apr 2011	N/A	$18.3m	Series B
Nov 2012	N/A	$3.1m	Early VC
Mar 2013	N/A	$13.5m	Series B
Oct 2015	Polaris Partners Flagship Pioneering RA Capital Management	$32.0m	Late VC
Dec 2017	N/A	$25.0m	Series B
Dec 2019*	Johnson & Johnson	N/A	Acquisition
Total Funding		AUD177m

Tech stackLearn more about the technologies and tools that this company uses.

Recent News about TARIS Biomedical